Pablo J Cagnoni - Net Worth and Insider Trading

Pablo J Cagnoni Net Worth

The estimated net worth of Pablo J Cagnoni is at least $3,767 dollars as of 2024-04-18. Pablo J Cagnoni is the Director of Rubius Therapeutics Inc and owns about 66,082 shares of Rubius Therapeutics Inc (RUBY) stock worth over $3,767. Pablo J Cagnoni is also the Director of CRISPR Therapeutics AG and owns about 0 shares of CRISPR Therapeutics AG (CRSP) stock worth over $0. Details can be seen in Pablo J Cagnoni's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pablo J Cagnoni has not made any transactions after 2023-02-01 and currently still holds the listed stock(s).

Transaction Summary of Pablo J Cagnoni

To

Pablo J Cagnoni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pablo J Cagnoni owns 6 companies in total, including Turmeric Acquisition Corp (TMPMU) , Fusion Pharmaceuticals Inc (FUSN) , and Rubius Therapeutics Inc (RUBY) among others .

Click here to see the complete history of Pablo J Cagnoni’s form 4 insider trades.

Insider Ownership Summary of Pablo J Cagnoni

Ticker Comapny Transaction Date Type of Owner
TMPMU Turmeric Acquisition Corp 2020-10-15 director
FUSN Fusion Pharmaceuticals Inc 2020-06-25 director
RUBY Rubius Therapeutics Inc 2023-02-01 director & Chief Executive Officer
CRSP CRISPR Therapeutics AG 2019-11-19 director
TMPM Turmeric Acquisition Corp 2020-10-15 director
INCY Incyte Corp 2023-06-07 President & R&D

Pablo J Cagnoni Latest Holdings Summary

Pablo J Cagnoni currently owns a total of 2 stocks. Among these stocks, Pablo J Cagnoni owns 66,082 shares of Rubius Therapeutics Inc (RUBY) as of February 1, 2023, with a value of $3,767 and a weighting of 100%. Pablo J Cagnoni also owns 0 shares of CRISPR Therapeutics AG (CRSP) as of November 19, 2019, with a value of $0 and a weighting of 0%.

Latest Holdings of Pablo J Cagnoni

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RUBY Rubius Therapeutics Inc 2023-02-01 66,082 0.06 3,767
CRSP CRISPR Therapeutics AG 2019-11-19 0 56.30 0

Holding Weightings of Pablo J Cagnoni


Pablo J Cagnoni Form 4 Trading Tracker

According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 4 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 8,448 shares on February 1, 2023, which brought Pablo J Cagnoni around $2,112.

According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 3 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 7,500 shares on November 19, 2019, which brought Pablo J Cagnoni around $465,000.

Insider Trading History of Pablo J Cagnoni

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pablo J Cagnoni Trading Performance

GuruFocus tracks the stock performance after each of Pablo J Cagnoni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pablo J Cagnoni is 30.14%. GuruFocus also compares Pablo J Cagnoni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pablo J Cagnoni within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pablo J Cagnoni's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pablo J Cagnoni

Average Relative Return

418.61%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 30.58 30.14 18.39 418.61 -34.19 -83.4
Relative Return to S&P 500(%) 30.35 17.79 -4.19 373.68 -58.42 -96.68

Pablo J Cagnoni Ownership Network

Ownership Network List of Pablo J Cagnoni

No Data

Ownership Network Relation of Pablo J Cagnoni


Pablo J Cagnoni Owned Company Details

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Pablo J Cagnoni is the director of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Executive Officer Luke Evnin , Chief Financial Officer Edward Hurwitz , and President Todd Foley .

Turmeric Acquisition Corp (TMPMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Turmeric Acquisition Corp Insider Transactions

No Available Data

Pablo J Cagnoni Mailing Address

Above is the net worth, insider trading, and ownership report for Pablo J Cagnoni. You might contact Pablo J Cagnoni via mailing address: Onyx Pharmaceuticals, Inc., 249 E. Grand Ave., South San Francisco Ca 94080.

Discussions on Pablo J Cagnoni

No discussions yet.